Low tier: under A$500
For lower-cost assistive technology needs. Exo Motion Pro's listed purchase price is above this tier.
Support at Home and AT-HM
Use the AT-HM self-check to identify questions for your provider. Funding depends on assessment and approval. If the product may suit you, an eligible free Sydney home visit can help you explore fitting and practical use.

Ask the provider to assess the proposed item against the person's goals and support plan. Exo Motion can supply specifications, fitting notes and a written quotation; assessment and approval remain with the relevant professionals.
The short answer
The Assistive Technology and Home Modifications scheme, usually shortened to AT-HM (sometimes written ATHM), provides separate funding for eligible people in the Australian Government Support at Home program. It is designed to help participants access assistive technology or home modifications connected to an assessed ageing-related need.
Exo Motion Pro is a lightweight hip-assist wearable robot for selected adults who can already walk independently. It provides powered assistance while the user walks, including on suitable flat routes, slopes and stairs. For an older person, the relevant question is not simply whether a product exists. The question is whether an assessor and provider consider it suitable for the person's goals, ability, environment, risks and approved support plan.
Exo Motion helps with the supplier side of that process. We offer a free consultation and eligible Sydney home visit, explain fitting and operating requirements, provide product specifications and prepare a written quotation. With written consent, we can contact the nominated care manager or Support at Home provider, send the documents, answer supplier questions and follow up. We do not conduct an aged-care needs assessment, prescribe the device, approve funding or guarantee a no-upfront-cost result.
Current funding structure
Australian Government guidance currently describes three assistive technology funding tiers. They are program limits, not an automatic allowance and not a guarantee that every participant can use the full amount.
Figures checked 14 September 2026 against the Department of Health AT-HM guidance, last updated 1 July 2026. Confirm the current allocation and contribution with your provider before ordering.
For lower-cost assistive technology needs. Exo Motion Pro's listed purchase price is above this tier.
A provider may consider this tier where the assessed item and supporting evidence fit current rules. A participant contribution or other payment may still be required.
For higher-cost assessed needs. Current guidance explains that additional evidence may be required in some circumstances. Approval remains individual.
AT-HM funding is generally expected to be used within a set period, commonly 12 months under current guidance. Participant contribution arrangements differ from prescription and wraparound clinical supports, which are generally fully funded. Your provider should explain the current contribution calculation, available balance and approval steps before you commit to a purchase.
Seven practical steps
Describe the activity that has become difficult: a local walk, shops, garden, community activity or suitable stairs. A specific goal is more useful than asking generally for an exoskeleton.
The intended user must be able to walk independently, follow fitting and operating instructions, be no taller than 190 cm and weigh between 40 kg and 150 kg. Clinical or falls concerns should be discussed with an appropriate professional.
Nominate your care partner or Support at Home provider and authorise Exo Motion to contact them about the product request. The provider may also require its own authority form.
Where available, Exo Motion provides a free consultation, personal fitting, short guided trial and training. Record what was attempted, comfort, confidence, supervision and whether the device felt useful for the agreed activity.
The assessor considers walking ability, falls risk, cognition, home and community environment, other mobility aids, goals, alternatives and the evidence required by the provider.
With consent, Exo Motion contacts the provider, supplies product details, fitting notes, safety information and a current quote, responds to questions and follows up on progress.
Do not assume funding is confirmed until the provider supplies its written decision, including the approved item, amount, contribution, ordering method and any follow-up requirements.
Who does what
Preparing a useful request
Use our short self-check, then tell us who your care manager or Support at Home provider is. With written consent, we can contact them and coordinate the product-side documents. The self-check is an information tool, not an eligibility decision.
Common questions
No. AT-HM is an assessed pathway. A qualified assessor and the participant's Support at Home provider determine whether an item is suitable, eligible and approved, the funding tier, and any participant contribution. Exo Motion cannot approve or guarantee funding.
The current AT-HM list includes a prescribed mobility category for assistive products for walking not manipulated by the arms, under ISO code 12 02. This category context does not mean Exo Motion Pro is automatically approved for a person. Individual goals, evidence, suitability and provider approval still matter.
Current Australian Government guidance describes low-tier funding below A$500, medium-tier funding up to A$2,000 and high-tier funding up to A$15,000, with additional evidence required in some higher-cost circumstances. The approved amount depends on assessed need and current program rules.
A participant contribution may apply to the assistive technology item depending on the person's circumstances and program rules. Prescription and wraparound clinical supports are generally fully funded under current guidance. The provider should confirm the amount before any order.
A trial can help the person, family and clinician observe fit, comfort, ability to follow instructions and practical usefulness. A trial is not a clinical assessment or a promise of approval, but it can provide useful real-world information for a considered decision.
The participant begins with their Support at Home provider or care partner, and a suitably qualified health professional may assess and prescribe the item. With written consent, Exo Motion can contact the nominated provider, supply specifications, fitting notes, a quotation and supplier information, answer questions and follow up. The provider remains responsible for any application, portal submission and funding decision.
If funding is not approved, a suitable customer can consider private purchase at A$2,499. Start with a free eligible Sydney consultation, home visit, fitting and guided trial before deciding. There is no purchase obligation. Any funded purchase requires written provider approval.
A private alternative
If funding is not approved, a suitable customer can consider private purchase at A$2,499. Start with a free eligible Sydney consultation, home visit, fitting and guided trial before deciding. There is no purchase obligation. Any funded purchase requires written provider approval.
Primary sources
Program rules can change. These official pages should be checked by the participant, family, assessor and provider before a funding decision.
Read the current funding, assessment, tier and contribution information.
Australian Government AT-HM guidanceReview the current inclusions, exclusions, categories and prescription requirements.
Australian Government AT-HM listUse the guide that matches your current question: payment, paperwork or checking the equipment category.
Questions about private payment, assessed funding and what the family may need to contribute.
Product details, consent, fitting notes and ordering questions for the care manager or OT.
Understand the category discussion without assuming that a particular product is approved.
The Support at Home program replaced Home Care Packages on 1 November 2025. If you have an old Level 1-4 package letter or unused funds, ask your current provider to check your transitioned status, unspent Commonwealth HCP funds and current support plan. An old approval letter is not a current device purchase authority.
Department guidance says transitioned participants use available unspent Commonwealth HCP funds for AT-HM first. A support plan review or reassessment may be needed where those funds are insufficient or needs have changed. The ongoing quarterly Support at Home budget is not interchangeable with the AT-HM allocation.
Bring your latest provider statement and Notice of Decision to the conversation. Ask who holds any unspent balance, whether the proposed item is approved and what you would personally pay. Exo Motion can supply a quote and answer product questions; the provider must confirm the funding route.
Read the Department's Support at Home overview and its AT-HM transition guidance.
Some people may have an approved funding pathway that covers eligible equipment, but free equipment is not a general entitlement and a supplier cannot promise it. Support at Home assistive technology funding depends on assessed needs and the provider process. Confirm what is approved and any customer costs before purchase.
For an Exo Motion walking-aid funding enquiry, start with the AT-HM preparation check, equipment-list explanation and supplier quote requirements. If the person is using an NDIS plan instead, read the NDIS guide; the two schemes are not interchangeable.
Local assessment and supplier support
Exo Motion is developing local occupational therapy partnerships in Melbourne, Brisbane, Perth, Adelaide and Hobart. Enquiries are open, but partners and appointment dates are not yet confirmed. You can use your own OT or ask your Support at Home provider to arrange an appropriate professional.
With written consent, we can send supplier information and a quote to your nominated OT and care manager. The clinician assesses suitability and prescription needs; the provider confirms the funding process and written approval. A local partnership does not make the device automatically funded, and our free eligible Sydney product visit is separate from a clinical assessment.
Choose the guide that matches your next decision. The self-check provides information, not a funding approval.
Leave your name and number. We normally respond within one business day. No health details or funding documents are needed here.